Early onset of natalizumab-related progressive multifocal leukoencephalopathy

Mult Scler. 2011 Nov;17(11):1397-8. doi: 10.1177/1352458511422929. Epub 2011 Sep 7.

Authors

A Damasceno, F von Glehn, A R M Martinez, A L F Longhini, L Deus-Silva, C O Brandão, L M B Santos, B P Damasceno

PMID: 21900356
DOI: 10.1177/1352458511422929

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Glatiramer Acetate
Humans
Immunologic Factors / adverse effects*
Immunosuppressive Agents / administration & dosage
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Leukoencephalopathy, Progressive Multifocal / diagnosis
Leukoencephalopathy, Progressive Multifocal / therapy
Male
Mianserin / administration & dosage
Mianserin / analogs & derivatives
Mirtazapine
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Natalizumab
Peptides / administration & dosage
Plasma Exchange
Treatment Outcome
Young Adult

Substances

Antibodies, Monoclonal, Humanized
Immunologic Factors
Immunosuppressive Agents
Natalizumab
Peptides
Mianserin
Glatiramer Acetate
Mirtazapine